Free Trial

The Biotech Growth Trust (LON:BIOG) Stock Crosses Below 50 Day Moving Average - Time to Sell?

The Biotech Growth Trust logo with Financial Services background

The Biotech Growth Trust PLC (LON:BIOG - Get Free Report)'s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 750.93 ($10.02) and traded as low as GBX 720 ($9.60). The Biotech Growth Trust shares last traded at GBX 734 ($9.79), with a volume of 45,707 shares changing hands.

The Biotech Growth Trust Price Performance

The company has a debt-to-equity ratio of 11.02, a quick ratio of 0.00 and a current ratio of 0.59. The company has a market capitalization of £210.72 million, a price-to-earnings ratio of 2.48 and a beta of 0.50. The company has a 50-day moving average price of GBX 748.67 and a 200-day moving average price of GBX 864.72.

The Biotech Growth Trust Company Profile

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in The Biotech Growth Trust Right Now?

Before you consider The Biotech Growth Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.

While The Biotech Growth Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines